Gvk Bio

Rediff.com » News » Gvk Bio

News for Gvk Bio

Business

Drugs of 7 Indian pharma firms in EMA's suspension list

Several drugs manufactured and marketed by as many as seven Indian generic pharmaceutical companies have been recommended for suspension by the European Medicines Agency (EMA) in its orders issued......

Germany bans GVK's 80 generic drugs for insufficient trials

Germany's drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical trials conducted by India's pharmaceutical research company GVK......

Clinical trials losing the plot in India

MNCs increasingly turning to emerging destinations in Southeast Asia due to clearer set of procedures, approvals.In 2000, it was projected as the next big thing to happen in healthcare, for its......

R&D firms should compensate trial injuries: DCGI

Contract research organisationsundertaking clinical trials of drugs on behalf of their multinational pharmaceutical clients will not be able to pass on the blame of trial-related injuries to their......

Pharma research outsourcing faces speed bumps

Venkat Jasti, vice-chairman and managing director of Suven Life Sciences, is an optimist on new drug discovery. But Suven's last major new drug discovery collaboration deal was more than two years......

Rediff News

Gvk Bio

News for Gvk Bio

Drugs of 7 Indian pharma firms in EMA's suspension list

Germany bans GVK's 80 generic drugs for insufficient trials

Clinical trials losing the plot in India

R&D firms should compensate trial injuries: DCGI

Pharma research outsourcing faces speed bumps

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS